Dual-Enzyme Responsive Peptides for Controlled Drug Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current enzyme-responsive systems are limited by requiring specific enzymes for activation, which restricts their modularity and effectiveness in targeted drug delivery and biodegradation, particularly in applications requiring response to multiple enzymes.

Innovation Solution

Development of dual-responsive peptides that require digestion by two separate enzymes to release a drug or active ingredient, utilizing a first enzyme to unmask a masked site and a second enzyme to cleave a protected bond, allowing for controlled release in specific enzymatic environments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If single enzyme responsive systems are used, then system simplicity is maintained, but target selectivity and effectiveness are limited

Engineering Contradiction:
Improvetarget selectivityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The peptide is divided into multiple functional segments: a first enzyme recognition sequence, a linker region containing a second enzyme recognition sequence, and a cargo region. This segmentation allows each segment to be independently optimized for specific enzyme recognition while maintaining overall system functionality, thereby improving target selectivity without excessive complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The peptide system is designed with multiple enzyme responsive elements that can recognize different enzymes (e.g., trypsin, chymotrypsin, caspases). This multi-functionality allows a single peptide construct to respond to multiple enzymatic triggers, enhancing adaptability and target selectivity across different disease contexts

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If enzyme cleavage sites are incorporated into materials, then selective biodegradation is enabled, but premature degradation occurs in non-specific locations

Engineering Contradiction:
Improvecontrolled release accuracyVSAvoidpremature degradation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The peptide is pre-designed with multiple enzyme recognition sequences in a specific arrangement, where the first enzyme cleaves a protective or masking sequence before the second enzyme can access its recognition site. This preliminary action ensures that the cargo is only released after sequential enzymatic processing, preventing premature degradation

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A linker sequence acts as an intermediary between the first and second enzyme recognition sites. This intermediary element is designed to be cleaved by the first enzyme, which then exposes or activates the second recognition site. The intermediary ensures proper sequential processing and prevents non-specific cleavage by either enzyme alone

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If trypsin responsive sequences are used, then drug release is enabled, but lack of specificity occurs due to widespread trypsin presence

Engineering Contradiction:
Improveenzyme cascade monitoringVSAvoidenzyme detection specificity
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

Multiple enzyme recognition sequences are merged into a single peptide construct, requiring sequential cleavage by different enzymes (e.g., trypsin followed by chymotrypsin, or caspase-3 followed by trypsin). This merging creates a logical AND gate where both enzymatic events must occur for cargo release, thereby achieving high detection specificity while maintaining versatility

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise and controlled release of drugs or active ingredients in targeted locations within the body, enhancing the modularity and effectiveness of enzyme-responsive systems by requiring sequential enzymatic digestion for activation.

Implementation Method 1

the enzyme substrate is digested by a first enzyme to unmask the ε-amine

Methodology Applied
Scientific EffectEnzymatic digestion: Enzyme

Implementation Method 2

a first enzyme selected from the group consisting of a chymotrypsin, a papain, a caspase 8 and a caspase 3

Methodology Applied
Scientific EffectProteolysis: Hydrolysis

Implementation Method 3

the bond between the α-carboxylic acid and the second group is cleaved by a second enzyme to release the second group

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Implementation Method 4

a second enzyme of trypsin

Methodology Applied
Scientific EffectProteolysis: Hydrolysis

Data Source

PatentUS11879019B2Dual-enzyme responsive peptides
Publication Date: 2024.01.23 RGT UNIV OF CALIFORNIA
  • US11879019B2 patent drawing
  • US11879019B2 patent drawing
  • US11879019B2 patent drawing

AI summary

An enzyme-responsive peptide and a method off using such enzyme-responsive peptide are disclosed. An enzyme-responsive peptide, the peptide comprising an amino acid having an α-amino group, an α-carboxylic acid group and a ε-amine group, wherein the ε-amine group is covalently bonded with a first group and the α-carboxylic acid is covalently bonded with a second group.